{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:17:28Z","timestamp":1793377048149,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is evidence that brain-derived neurotropic factor (BDNF) plays a protective role in the brain. Peripheral levels of BDNF correlate with its concentration in the brain. Previous studies have revealed lower serum BDNF levels in patients with mental illnesses. In most studies serum BDNF correlates negatively with psychiatric disorders and disease severity. Most studies in this field are on psychiatric diagnosis and personality traits. The aim of our study is to explore associations between general psychiatric symptoms, independent of diagnostic groups, and serum BDNF as well as the inflammatory biomarker high-sensitive CRP (hs-CRP). Comparison between the group regularly using psychotropic medication and those not using psychotropic medication is conducted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study is a cross sectional study with 132 participants from a general open inpatient psychiatric ward at the Nordland Hospital Trust, Bodoe, Norway. Participants were assessed on serum levels of BDNF and hs-CRP. Psychiatric symptoms were assessed by a self-rating scale (Symptom check list, SCL-90- R). Multiple linear regression model was used for statistical analyses of associations between levels of BDNF, hs-CRP and symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found a positive association (<jats:italic>p<\/jats:italic> &lt; 0.05), for most SCL-90 symptom clusters with BDNF in the psychotropic medication-free group. No associations were found in the group of patients using psychotropic medication, except one, the paranoid ideation cluster (<jats:italic>p<\/jats:italic> 0.022). No associations were found between hs-CRP and symptom clusters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We found no relation between symptom clusters and the inflammatory biomarker hs-CRP. Serum BDNF levels were positively associated with intensity of psychiatric symptoms in the group of patients not using psychotropic medication. Our findings are in conflict with several previous studies reporting increased hs-CRP as well as decreased rather than increased BDNF in mental suffering. Patients on psychotropic medication may not require the same upregulation because the medication is modulating the underlying biological pathology.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-022-03744-2","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T15:03:35Z","timestamp":1643900615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association between brain-derived neurotropic factor (BDNF), high-sensitivity C-reactive protein (hs-CRP) and psychiatric symptoms in medicated and unmedicated patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Hedda","family":"Soloey-Nilsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Nygaard-Odeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnhild Gangsoey","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Lars","family":"Brekke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom Eirik","family":"Mollnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveig Klaebo","family":"Reitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terje","family":"Oiesvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"issue":"1","key":"3744_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5498\/wjp.v5.i1.154","volume":"5","author":"A Toll","year":"2015","unstructured":"Toll A, Mane A. Brain-derived neurotrophic factor levels in first episode of psychosis: a systematic review. World J Psychiatry. 2015;5(1):154\u20139.","journal-title":"World J Psychiatry"},{"issue":"12","key":"3744_CR2","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","volume":"37","author":"W Pan","year":"1998","unstructured":"Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998;37(12):1553\u201361.","journal-title":"Neuropharmacology"},{"issue":"3","key":"3744_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0304-3940(02)00529-3","volume":"328","author":"F Karege","year":"2002","unstructured":"Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002;328(3):261\u20134.","journal-title":"Neurosci Lett"},{"issue":"4","key":"3744_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1017\/S1461145709991015","volume":"13","author":"A Pillai","year":"2010","unstructured":"Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H, et al. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol. 2010;13(4):535\u20139.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3744_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12888-015-0413-1","volume":"15","author":"H Nomoto","year":"2015","unstructured":"Nomoto H, Baba H, Satomura E, Maeshima H, Takebayashi N, Namekawa Y, et al. Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression. BMC Psychiatry. 2015;15:33.","journal-title":"BMC Psychiatry"},{"issue":"7","key":"3744_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/mp.2013.172","volume":"19","author":"BS Fernandes","year":"2014","unstructured":"Fernandes BS, Berk M, Turck CW, Steiner J, Goncalves CA. Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. Mol Psychiatry. 2014;19(7):750\u20131.","journal-title":"Mol Psychiatry"},{"key":"3744_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13098-018-0367-9","volume":"10","author":"JR Kim","year":"2018","unstructured":"Kim JR, Kim HN, Song SW. Associations among inflammation, mental health, and quality of life in adults with metabolic syndrome. Diabetol Metab Syndr. 2018;10:66.","journal-title":"Diabetol Metab Syndr"},{"key":"3744_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.","journal-title":"Front Immunol"},{"issue":"4","key":"3744_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00127-015-1033-2","volume":"50","author":"P Bebbington","year":"2015","unstructured":"Bebbington P. Categories, continua and the growth of psychiatric knowledge. Soc Psychiatry Psychiatr Epidemiol. 2015;50(4):507\u201310.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"1","key":"3744_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1176\/appi.ajp.2010.10111655","volume":"168","author":"SE Hyman","year":"2011","unstructured":"Hyman SE. Grouping diagnoses of mental disorders by their common risk factors. Am J Psychiatry. 2011;168(1):1\u20133.","journal-title":"Am J Psychiatry"},{"key":"3744_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-7682-3-1","volume":"3","author":"SE Lakhan","year":"2010","unstructured":"Lakhan SE, Vieira K, Hamlat E. Biomarkers in psychiatry: drawbacks and potential for misuse. Int Arch Med. 2010;3:1.","journal-title":"Int Arch Med"},{"key":"3744_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-244X-13-13","volume":"13","author":"T Oiesvold","year":"2013","unstructured":"Oiesvold T, Nivison M, Hansen V, Skre I, Ostensen L, Sorgaard KW. Diagnosing comorbidity in psychiatric hospital: challenging the validity of administrative registers. BMC Psychiatry. 2013;13:13.","journal-title":"BMC Psychiatry"},{"key":"3744_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbi.2019.06.010","volume":"81","author":"N Groven","year":"2019","unstructured":"Groven N, Fors EA, Reitan SK. Patients with fibromyalgia and chronic fatigue syndrome show increased hsCRP compared to healthy controls. Brain Behav Immun. 2019;81:172\u20137.","journal-title":"Brain Behav Immun"},{"issue":"9","key":"3744_CR14","doi-asserted-by":"publisher","first-page":"e0222242","DOI":"10.1371\/journal.pone.0222242","volume":"14","author":"JB Larsen","year":"2019","unstructured":"Larsen JB, Stunes AK, Vaaler A, Reitan SK. Cytokines in agitated and non-agitated patients admitted to an acute psychiatric department: a cross-sectional study. PLoS One. 2019;14(9):e0222242.","journal-title":"PLoS One"},{"issue":"2","key":"3744_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1023\/A:1008931926181","volume":"9","author":"N Schmitz","year":"2000","unstructured":"Schmitz N, Hartkamp N, Kiuse J, Franke GH, Reister G, Tress W. The symptom check-list-90-R (SCL-90-R): a German validation study. Qual Life Res. 2000;9(2):185\u201393.","journal-title":"Qual Life Res"},{"issue":"3","key":"3744_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/08039488.2017.1415373","volume":"72","author":"M Skibinska","year":"2018","unstructured":"Skibinska M, Kapelski P, Rajewska-Rager A, Pawlak J, Szczepankiewicz A, Narozna B, et al. Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters. Nord J Psychiatry. 2018;72(3):191\u20136.","journal-title":"Nord J Psychiatry"},{"issue":"2","key":"3744_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/mp.2015.54","volume":"21","author":"K Munkholm","year":"2016","unstructured":"Munkholm K, Vinberg M, Kessing LV. Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis. Mol Psychiatry. 2016;21(2):216\u201328.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"3744_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1099800417735634","volume":"20","author":"SS Binford","year":"2018","unstructured":"Binford SS, Hubbard EM, Flowers E, Miller BL, Leutwyler H. Serum BDNF Is positively associated with negative symptoms in older adults with schizophrenia. Biol Res Nurs. 2018;20(1):63\u20139.","journal-title":"Biol Res Nurs"},{"issue":"1","key":"3744_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/WNN.0000000000000089","volume":"29","author":"S Kheirouri","year":"2016","unstructured":"Kheirouri S, Noorazar SG, Alizadeh M, Dana-Alamdari L. Elevated brain-derived neurotrophic factor correlates negatively with severity and duration of major depressive episodes. Cogn Behav Neurol. 2016;29(1):24\u201331.","journal-title":"Cogn Behav Neurol"},{"issue":"1","key":"3744_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.9758\/cpn.2014.12.1.37","volume":"12","author":"K Atake","year":"2014","unstructured":"Atake K, Yoshimura R, Hori H, Katsuki A, Ikenouchi-Sugita A, Umene-Nakano W, et al. Duloxetine, a selective noradrenaline reuptake inhibitor, increased plasma levels of 3-methoxy-4-hydroxyphenylglycol but not homovanillic acid in patients with major depressive disorder. Clin Psychopharmacol Neurosci. 2014;12(1):37\u201340.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"1","key":"3744_CR21","first-page":"21","volume":"22","author":"H Hori","year":"2007","unstructured":"Hori H, Yoshimura R, Yamada Y, Ikenouchi A, Mitoma M, Ida Y, et al. Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients. Int Clin Psychopharmacol. 2007;22(1):21\u20137.","journal-title":"Int Clin Psychopharmacol"},{"issue":"2-3","key":"3744_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.psychres.2010.07.023","volume":"186","author":"K Okuno","year":"2011","unstructured":"Okuno K, Yoshimura R, Ueda N, Ikenouchi-Sugita A, Umene-Nakano W, Hori H, et al. Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan. Psychiatry Res. 2011;186(2-3):326\u201332.","journal-title":"Psychiatry Res"},{"key":"3744_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.bbi.2017.02.020","volume":"62","author":"O Kohler-Forsberg","year":"2017","unstructured":"Kohler-Forsberg O, Buttenschon HN, Tansey KE, Maier W, Hauser J, Dernovsek MZ, et al. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav Immun. 2017;62:344\u201350.","journal-title":"Brain Behav Immun"},{"key":"3744_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.psyneuen.2017.02.035","volume":"81","author":"M Tayefi","year":"2017","unstructured":"Tayefi M, Shafiee M, Kazemi-Bajestani SMR, Esmaeili H, Darroudi S, Khakpouri S, et al. Depression and anxiety both associate with serum level of hs-CRP: a gender-stratified analysis in a population-based study. Psychoneuroendocrinology. 2017;81:63\u20139.","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"3744_CR25","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jpsychires.2012.05.003","volume":"46","author":"B Elfving","year":"2012","unstructured":"Elfving B, Buttenschon HN, Foldager L, Poulsen PH, Andersen JH, Grynderup MB, et al. Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level. J Psychiatr Res. 2012;46(9):1118\u201325.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"3744_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.psyneuen.2010.07.013","volume":"36","author":"BA Bus","year":"2011","unstructured":"Bus BA, Molendijk ML, Penninx BJ, Buitelaar JK, Kenis G, Prickaerts J, et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology. 2011;36(2):228\u201339.","journal-title":"Psychoneuroendocrinology"},{"issue":"20","key":"3744_CR27","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa021993","volume":"347","author":"PM Ridker","year":"2002","unstructured":"Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557\u201365.","journal-title":"N Engl J Med"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-03744-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-022-03744-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-03744-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T15:03:39Z","timestamp":1643900619000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-022-03744-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3744"],"URL":"https:\/\/doi.org\/10.1186\/s12888-022-03744-2","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]},"assertion":[{"value":"6 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regional Ethics Committee North, notification 2015\/1809\/REK Nord. All methods were performed in accordance with the relevant guidelines and regulations, and written informed consent.A research nurse informed eligible patients about the study and written informed concent was obtained by a doctor administering the clinical assessments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declared no conflicts of interests with respect to their authorship or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}